TP53 and pancreatic adenocarcinoma: In order to comprehensively assess the clinical significance of MVP, we evaluated the correlation between distinct clinical parameters (race, tumor grade, pancreatitis status, and TP53 mutation status) of PAAD and the expression levels of MVP using the UALCAN database.